Patents by Inventor Scott E. Conner

Scott E. Conner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • cGAS INHIBITORS
    Publication number: 20230391786
    Abstract: The present invention relates to novel cGAS inhibitor compounds, to pharmaceutical compositions comprising the compounds, and to methods of using the compounds and compositions to treat certain pathological conditions.
    Type: Application
    Filed: June 1, 2023
    Publication date: December 7, 2023
    Inventors: Adel AHMED, Christina MARTINEZ BROKAW, Cheryl Ann CARSON, Scott E. CONNER, Kevin Charles FORTNER, Jeffry B. FRANCISKOVICH, Douglas L. GERNERT, Steven J. GREEN, Charles W. LUGAR, III, Jothirajah MARIMUTHU, Shanthi NAGARAJAN, Christodoulos NICOLAOU, Emmanuel ONOBUN, Stephanie Lange STOUT, Eric G. TROMICZAK, Thibault VARIN
  • 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
    Patent number: 6620839
    Abstract: Compounds of formula I are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands. Also disclosed are histamine-3 receptor ligand compositions and methods of antagonizing or agonizing histamine-3 receptors.
    Type: Grant
    Filed: January 11, 2002
    Date of Patent: September 16, 2003
    Assignee: Abbott Laboratories
    Inventors: Yousseff L. Bennani, Ramin Faghih, Wesley J. Dwight, Anil Vasudevan, Scott E. Conner
  • 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
    Patent number: 6515013
    Abstract: Compounds of formula I are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands. Also disclosed are histamine-3 receptor ligand compositions and methods of antagonizing or agonizing histamine-3 receptors.
    Type: Grant
    Filed: July 11, 2001
    Date of Patent: February 4, 2003
    Assignee: Abbott Laboratories
    Inventors: Youssef L. Bennani, Ramin Faghih, Wesley J. Dwight, Anil Vasudevan, Scott E. Conner
  • 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
    Publication number: 20020137931
    Abstract: Compounds of formula I 1
    Type: Application
    Filed: January 11, 2002
    Publication date: September 26, 2002
    Inventors: Yousseff L. Bennani, Ramin Faghih, Wesley J. Dwight, Anil Vasudevan, Scott E. Conner
  • 1,3-Disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
    Publication number: 20020035103
    Abstract: Compounds of formula I 1
    Type: Application
    Filed: July 11, 2001
    Publication date: March 21, 2002
    Inventors: Youssef L. Bennani, Ramin Faghih, Wesley J. Dwight, Anil Vasudevan, Scott E. Conner